These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17646202)

  • 1. Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
    Capilla J; Clemons KV; Sobel RA; Stevens DA
    J Antimicrob Chemother; 2007 Sep; 60(3):673-6. PubMed ID: 17646202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.
    Clemons KV; Capilla J; Sobel RA; Martinez M; Tong AJ; Stevens DA
    Antimicrob Agents Chemother; 2009 May; 53(5):1858-62. PubMed ID: 19273680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
    Clemons KV; Sobel RA; Williams PL; Pappagianis D; Stevens DA
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2420-6. PubMed ID: 12121913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Ophthalmic Res; 2004; 36(3):172-6. PubMed ID: 15103209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
    Sharkey PK; Graybill JR; Johnson ES; Hausrath SG; Pollard RB; Kolokathis A; Mildvan D; Fan-Havard P; Eng RH; Patterson TF; Pottage JC; Simberkoff MS; Wolf J; Meyer RD; Gupta R; Lee LW; Gordon DS
    Clin Infect Dis; 1996 Feb; 22(2):315-21. PubMed ID: 8838189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experience is CLEAR.
    Chandrasekar P
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
    Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.
    Kamberi P; Sobel RA; Clemons KV; Waldvogel A; Striebel JM; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2007 Mar; 51(3):998-1003. PubMed ID: 17178793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
    Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B lipid complex.
    Rapp RP; Gubbins PO; Evans ME
    Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.
    Cannon JP; Fiscella R; Pattharachayakul S; Garey KW; De Alba F; Piscitelli S; Edward DP; Danziger LH
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2112-7. PubMed ID: 12714650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
    Blowey DL; Garg UC; Kearns GL; Warady BA
    Adv Perit Dial; 1998; 14():247-50. PubMed ID: 10649734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
    Sorensen KN; Sobel RA; Clemons KV; Calderon L; Howell KJ; Irani PR; Pappagianis D; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3087-91. PubMed ID: 11036027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
    López-Vélez R; Videla S; Márquez M; Boix V; Jiménez-Mejías ME; Górgolas M; Arribas JR; Salas A; Laguna F; Sust M; Cañavate C; Alvar J;
    J Antimicrob Chemother; 2004 Mar; 53(3):540-3. PubMed ID: 14739148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amphotericin B--lipid complex].
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):53. PubMed ID: 9147519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.